Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease
- 20 September 2011
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 35 (2) , 363-367
Abstract
Cerebral micro‐ and macro‐vasculopathy have been described in Fabry disease (FD). Neuronal globotriaosylceramide accumulation in selective cortical and brain stem areas including the hippocampus has been reported by autopsy studies in FD, but clinical surrogates as well as the clinical relevance of these findings have not been investigated so far. We measured the hippocampus volumes in a group of clinically affected patients with FD and correlated the findings with the cognitive performance of the patients. Hippocampal volumes were determined manually on T1‐weighted MR‐images of 25 FD patients (age 36.5 ± 11.0 years) and 20 age‐matched controls. Additionally, individual white matter (WM) and gray matter (GM) volumes were measured using brain segmentation analyses. After controlling for age, white matter lesion (WML) volume, and WM/GM‐volumes hippocampal volumes were significantly decreased in FD. These findings were substantially more pronounced in a subgroup of men with FD. WM and WM/GM volumes, and memory function did not significantly differ between patients and controls. In patients with FD hippocampal volumes were neither significantly correlated to WML volume nor to WM or WM/GM volumes. Hippocampus atrophy was not driven by the WML or other brain tissue atrophy and seems to correlate with the neuronal involvement in FD. In this young to middle‐aged Fabry cohort the hippocampus degeneration was functionally compensated without memory impairment. Longitudinal studies are needed to determine whether this degenerative component in FD will progress and, in concert with the individual WML‐load, predict subsequent cognitive decline.Keywords
This publication has 19 references indexed in Scilit:
- Neuropsychiatric symptoms and brain structural alterations in Fabry diseaseEuropean Journal of Neurology, 2011
- Brain Atrophy and Cerebral Small Vessel DiseaseStroke, 2011
- Association of White-Matter Lesions with Brain Atrophy Markers: The Three-City Dijon MRI StudyCerebrovascular Diseases, 2009
- Diagnostic utility of different MRI and MR angiography measures in Fabry diseaseNeurology, 2009
- Voxel based analyses of diffusion tensor imaging in Fabry diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- The Mainz Severity Score Index: a new instrument for quantifying the Anderson–Fabry disease phenotype, and the response of patients to enzyme replacement therapyClinical Genetics, 2004
- Voxel-Based Morphometry—The MethodsNeuroImage, 2000
- Cerebrovascular complications of Fabry's diseaseAnnals of Neurology, 1996
- Fabry disease: Immunocytochemical characterization of neuronal involvementAnnals of Neurology, 1992
- Nervous system involvement in Fabry's disease: Clinicopathological and biochemical correlationAnnals of Neurology, 1988